04/29/2025 5:30 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 4:49 PM | Abbott Laboratories (Issuer) McDew Darren W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 4:58 PM | Abbott Laboratories (Issuer) McKinstry Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 5:06 PM | Abbott Laboratories (Issuer) O'Grady Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 5:14 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 5:22 PM | Abbott Laboratories (Issuer) STARKS DANIEL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 4:19 PM | Abbott Laboratories (Issuer) Blount Sally E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 4:30 PM | Abbott Laboratories (Issuer) Gonzalez Patricia Paola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 4:40 PM | Abbott Laboratories (Issuer) Kumbier Michelle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2025 3:10 PM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2025 6:36 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ABT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Abbott Laboratories and its competitors with MarketBeat's FREE daily newsletter.
|
04/02/2025 4:39 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2025 4:30 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2025 4:05 PM | Abbott Laboratories (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 5:55 PM | Abbott Laboratories (Issuer) Earnhardt Lisa D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 5:28 PM | Abbott Laboratories (Subject) Earnhardt Lisa D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025 4:47 PM | Abbott Laboratories (Subject) Earnhardt Lisa D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:54 PM | Abbott Laboratories (Issuer) Salvadori Daniel Gesua Sive (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:00 PM | Abbott Laboratories (Issuer) Shroff Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:05 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:33 PM | Abbott Laboratories (Issuer) Ford Robert B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:39 PM | Abbott Laboratories (Issuer) MCCOY JOHN A. JR. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:44 PM | Abbott Laboratories (Issuer) Moreland Mary K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:21 PM | Abbott Laboratories (Issuer) Boudreau Philip P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:27 PM | Abbott Laboratories (Issuer) Earnhardt Lisa D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:00 PM | Abbott Laboratories (Issuer) ALLEN HUBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 7:40 PM | Abbott Laboratories (Subject) Shroff Eric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 7:29 PM | Abbott Laboratories (Issuer) Shroff Eric (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/03/2025 6:58 PM | Abbott Laboratories (Subject) Moreland Mary K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 7:08 PM | Abbott Laboratories (Subject) Morrone Louis H. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 7:18 PM | Abbott Laboratories (Subject) Wainer Andrea F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 6:52 PM | Abbott Laboratories (Subject) MCCOY JOHN A. JR. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 5:47 PM | Abbott Laboratories (Issuer) Salvadori Daniel Gesua Sive (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 5:56 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 5:07 PM | Abbott Laboratories (Issuer) Ford Robert B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 5:17 PM | Abbott Laboratories (Issuer) MCCOY JOHN A. JR. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 5:26 PM | Abbott Laboratories (Issuer) Moreland Mary K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 5:35 PM | Abbott Laboratories (Issuer) Morrone Louis H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 4:37 PM | Abbott Laboratories (Issuer) ALLEN HUBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 4:46 PM | Abbott Laboratories (Issuer) Boudreau Philip P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2025 4:51 PM | Abbott Laboratories (Issuer) Ford Robert B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
02/05/2025 5:52 PM | Abbott Laboratories (Subject) Ford Robert B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 6:08 PM | Abbott Laboratories (Issuer) Salvadori Daniel Gesua Sive (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 6:16 PM | Abbott Laboratories (Issuer) ALLEN HUBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 6:33 PM | Abbott Laboratories (Issuer) Morrone Louis H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 4:33 PM | Abbott Laboratories (Subject) ALLEN HUBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025 4:26 PM | Abbott Laboratories (Subject) Salvadori Daniel Gesua Sive (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 4:30 PM | Abbott Laboratories (Subject) ALLEN HUBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 6:13 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2025 4:26 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2024 4:14 PM | Abbott Laboratories (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024 4:10 PM | Abbott Laboratories (Issuer) ALLEN HUBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 6:37 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 4:27 PM | Abbott Laboratories (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 4:33 PM | Abbott Laboratories (Issuer) Gonzalez Patricia Paola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 4:39 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 4:48 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:24 PM | Abbott Laboratories (Issuer) Ford Robert B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 5:20 PM | Abbott Laboratories (Subject) Ford Robert B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 7:03 PM | Abbott Laboratories (Issuer) Boudreau Philip P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 6:52 PM | Abbott Laboratories (Issuer) MCCOY JOHN A. JR. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:02 PM | Abbott Laboratories (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024 6:37 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 3:39 PM | Abbott Laboratories (Issuer) Morrone Louis H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 3:30 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |